‘In the long-term interests:’ FDA oncology chief defends rejection of Lilly, Innovent cancer drug
‘In the long-term interests:’ FDA oncology chief defends rejection of [...]
AAD 2022: Incyte’s latest Opzelura data show med’s benefit grows over time in vitiligo
AAD 2022: Incyte’s latest Opzelura data show med’s benefit grows [...]
Jazz grows cannabinoid manufacturing ambitions with new $100M plant
Jazz grows cannabinoid manufacturing ambitions with new $100M plant fkansteiner [...]
Gilead, after 11% revenue increase in 2021, rewards CEO O’Day with $19.2M pay package
Gilead, after 11% revenue increase in 2021, rewards CEO O’Day [...]
Bristol Myers Squibb, Merck hit setback in bid to expand Reblozyl’s anemia nod
Bristol Myers Squibb, Merck hit setback in bid to expand [...]
AAD 2022: Eli Lilly plugs Olumiant 52-week data as JAK inhibitor looks to fill out label with industry-first alopecia nod
AAD 2022: Eli Lilly plugs Olumiant 52-week data as JAK [...]
Moderna weighs private market debut for COVID shot as federal funding flounders
Moderna weighs private market debut for COVID shot as federal [...]
Fierce Pharma Asia—Chinese biotech’s Pfizer trade secret suit; Lilly, Innovent’s FDA rebuff; Aurobindo’s New Jersey closure
Fierce Pharma Asia—Chinese biotech’s Pfizer trade secret suit; Lilly, Innovent’s [...]
After Supreme Court win, Merck prevails against 500 Fosamax cases: report
After Supreme Court win, Merck prevails against 500 Fosamax cases: [...]
Sun Pharma forks over $485M to settle long-running legal battle inherited in Ranbaxy buyout
Sun Pharma forks over $485M to settle long-running legal battle [...]